Once considered cellular junk, non-coding RNAs are emerging as key players in everything from brain development to cancer — ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still ...

A protein called LENG8 traps defective RNA molecules inside the cell nucleus before they can reach the cytoplasm and disrupt normal cellular function, according to a study published in Molecular Cell ...

In his new book, “The Catalyst,” Dr. Thomas Cech describes how mRNA in the COVID vaccines encodes the virus’s spike protein. The following is an excerpt from The Catalyst: RNA and the Quest to Unlock ...

Exsilio Therapeutics launched on Wednesday with an $82 million series A fundraising round co-led by Novartis Venture Fund and Delos Capital. The company’s interim CEO, Tal Zaks, says that while ...

Johns Hopkins University, home to considerable expertise in RNA sciences and therapeutic development, has announced a new academic collaboration with TriLink BioTechnologies, part of Maravai ...

SHANGHAI/SUZHOU, China, April 19 (Reuters) - China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology ...

< Photo 1. (From left) Professor Won Do Heo and Jihwan Yu, a Ph.D. Candidate of the Department of Biological Sciences > CRISPR-Cas13, a powerful RNA-targeting technology is gaining increasing ...

A team at UT Southwestern Medical Center has identified a structural trick that lets viruses translate their genetic code inside human cells, even when that code is riddled with “bad” codons the host ...